Omega Therapeutics, Inc.
(NASDAQ : OMGA)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -2.15%182.820.0%$887.85m
AMGNAmgen, Inc. 0.28%246.941.5%$593.68m
NVAXNovavax, Inc. -5.65%56.8675.7%$435.69m
VRTXVertex Pharmaceuticals, Inc. 2.04%293.911.9%$428.44m
GILDGilead Sciences, Inc. 0.87%61.621.0%$375.51m
REGNRegeneron Pharmaceuticals, Inc. 2.80%630.822.6%$354.11m
SNSSSunesis Pharmaceuticals, Inc. 1.42%3.930.7%$274.72m
ILMNIllumina, Inc. -0.48%222.693.3%$240.36m
BIIBBiogen, Inc. -0.12%217.931.8%$200.98m
GOVXGeoVax Labs, Inc. -10.56%2.880.0%$143.48m
BNTXBioNTech SE -8.11%168.260.0%$140.88m
CRSPCRISPR Therapeutics AG -0.44%81.040.6%$132.18m
RYTMRhythm Pharmaceuticals, Inc. 4.94%21.240.0%$95.80m
PLRXPliant Therapeutics, Inc. 0.08%18.930.0%$95.51m
BMRNBioMarin Pharmaceutical, Inc. -0.19%95.644.2%$95.15m

Company Profile

Omega Therapeutics, Inc. engages in the development of DNA-sequence-targeting and mRNA-encoded therapeutics. It offers its product under the OMEGA platform. The company was founded by Noubar B. Afeyan and David Berry on July 13, 2016 and is headquartered in Cambridge, MA.